Consultation between the GPEI and Poliovirus Vaccine Manufacturers, NACs and NRAs

The Consultation between the GPEI and the Poliovirus Vaccine Manufacturers, National Authorities for Containment (NACs) and National Regulatory Authorities (NRAs) is an important annual event that aims to enable vaccine manufacturers to optimally plan their production over the span of the current eradication strategy.

• 21st WHO/UNICEF Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 11 October, 2022, Geneva, Switzerland
• 20th WHO/UNICEF Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 12 – 13 October, 2021, virtual
• 19th WHO/UNICEF Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 12 – 13 October, 2020, virtual
• 18th WHO/UNICEF Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 15 October, 2019, Geneva, Switzerland
• 17th WHO/UNICEF Consultation  with OPV/IPV Manufacturers and National Authorities for Containment, 9 October 2018, Geneva, Switzerland